Cefepime trough levels and clinical outcomes in patients undergoing universal therapeutic drug monitoring: A prospective cohort study
Mia Madeleine Lidén(University Hospital of Geneva), Angela Huttner(University Hospital of Geneva), Dionysios Neofytos(Johns Hopkins University), Pierre Lescuyer(University Hospital of Geneva), Stavroula Masouridi‐Levrat(University of Geneva), Yves Chalandon(University of Geneva), David Tonoli(University Hospital of Geneva), Elodie von Dach(University Hospital of Geneva)
Cited by 4
Related Papers
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
|Journal of Clinical Oncology|2009|562
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
|Antimicrobial Resistance and Infection Control|2013|454
Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia
|Blood|2015|377
Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2016|347